Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials.

Holpuch AS, Desai KG, Schwendeman SP, Mallery SR.

J Carcinog. 2011;10:23. doi: 10.4103/1477-3163.85185. Epub 2011 Sep 21.

2.

Chemoprevention of oral cancer: Green tea experience.

Ramshankar V, Krishnamurthy A.

J Nat Sci Biol Med. 2014 Jan;5(1):3-7. doi: 10.4103/0976-9668.127272. Review.

3.

Chemoprevention of premalignant and malignant lesions of oral cavity: Recent trends.

Bodhade AS, Dive AM.

Eur J Dent. 2013 Apr;7(2):246-50. doi: 10.4103/1305-7456.110198. Review.

4.
5.

Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.

Ho MW, Field EA, Field JK, Risk JM, Rajlawat BP, Rogers SN, Steele JC, Triantafyllou A, Woolgar JA, Lowe D, Shaw RJ.

Br J Oral Maxillofac Surg. 2013 Oct;51(7):594-9. doi: 10.1016/j.bjoms.2013.03.014. Epub 2013 Apr 16.

PMID:
23601832
6.

Retinoids: application in premalignant lesions and oral cancer.

Contreras Vidaurre EG, Bagán Sebastián JV, Gavalda C, Torres Cifuentes EF.

Med Oral. 2001 Mar-Apr;6(2):114-23. Review. English, Spanish.

PMID:
11500628
7.

Development of chemopreventive agents for lung and upper aerodigestive tract cancers.

Kelloff GJ, Boone CW, Steele VK, Perloff M, Crowell J, Doody LA.

J Cell Biochem Suppl. 1993;17F:2-17. Review.

PMID:
8412195
8.

Lung cancer chemoprevention.

Keith RL.

Proc Am Thorac Soc. 2012 May;9(2):52-6. doi: 10.1513/pats.201107-038MS.

9.

The chemopreventive properties and therapeutic modulation of green tea polyphenols in oral squamous cell carcinoma.

Lee UL, Choi SW.

ISRN Oncol. 2011;2011:403707. doi: 10.5402/2011/403707. Epub 2011 May 16.

10.

Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.

Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC.

Cancer Res. 1994 Apr 1;54(7 Suppl):2015s-2024s. Review.

11.

Chemoprevention of prostate cancer: concepts and strategies.

Kelloff GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovitch L, Malone WA, Crowell JA, Sigman CC.

Eur Urol. 1999;35(5-6):342-50. Review.

PMID:
10325487
12.

Risk biomarkers and current strategies for cancer chemoprevention.

Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk E, Malone WF, Steele VE, Lubet RA, Sigman CC.

J Cell Biochem Suppl. 1996;25:1-14. Review.

PMID:
9027592
13.

Development of chemopreventive agents for bladder cancer.

Kelloff GJ, Boone CW, Malone WF, Steele VE, Doody LA.

J Cell Biochem Suppl. 1992;16I:1-12. Review.

PMID:
1305671
14.

Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.

Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK.

J Natl Cancer Inst. 1993 Jan 6;85(1):44-7.

PMID:
8416256
15.

Chemoprevention of squamous cell carcinoma of the head and neck.

Wrangle JM, Khuri FR.

Curr Opin Oncol. 2007 May;19(3):180-7. Review.

PMID:
17414634
16.

Chemoprevention strategies for pancreatic cancer.

Stan SD, Singh SV, Brand RE.

Nat Rev Gastroenterol Hepatol. 2010 Jun;7(6):347-56. doi: 10.1038/nrgastro.2010.61. Epub 2010 May 4. Review.

17.

Chemoprevention for prostatic intraepithelial neoplasia.

Nelson PS, Gleason TP, Brawer MK.

Eur Urol. 1996;30(2):269-78. Review.

PMID:
8875211
18.

Chemoprevention of lung cancer.

Keith RL.

Proc Am Thorac Soc. 2009 Apr 15;6(2):187-93. doi: 10.1513/pats.200807-067LC. Review.

19.

Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.

Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk E, Steele VE, Lubet RA, Sigman CC.

J Cell Biochem Suppl. 1995;23:1-9. Review.

PMID:
8747372
20.

Lung cancer chemoprevention: current status and future prospects.

Keith RL, Miller YE.

Nat Rev Clin Oncol. 2013 Jun;10(6):334-43. doi: 10.1038/nrclinonc.2013.64. Epub 2013 May 21. Review.

Supplemental Content

Support Center